In the fields of in vitro diagnostics, high-value consumables, and rehabilitation equipment, how can the right development path be identified through upstream-downstream supply chain collaboration, upgrading of technological and industrial foundations, and coordinated integration of key industry development factors?June 22, 2021,2021 The 3rd International Summit on Medical Device Innovationwill be held onChina · Nanjingheld. This event will center on“Intelligent Manufacturing as the Foundation, Collaborative Innovation”Centered on this theme, the event will bring together the most active medical device innovation companies, listed firms, financial institutions, and healthcare organizations from China and abroad through formats such as the Medical Device Vitality Rankings, closed-door government-enterprise meetings, overseas live connections, keynote speeches, and pioneer dialogues, creating a premier offline gathering for the medical device industry.
This event is hosted by the Nanjing New Medicine and Life Health Industry Chain Task Force and the People's Government of Gaochun District, Nanjing City; organized by the Office of the Innovation Committee of the CPC Gaochun District Committee and VCBeat; and co-organized by Jiangsu Gaochun Economic Development Zone and Jiangsu Gaochun High-Tech Industrial Development Zone.
Deng Jianmin, Senior Vice President of BD Worldwide and General Manager of Greater ChinaConfirmed attendance at the 3rd International Summit on Medical Device Innovation, where a related presentation will be delivered.
Click the image to register

Deng Jianmin,Senior Vice President, Global; General Manager, Greater China, BD
Mr. Deng Jianmin currently serves as a member of BD’s Global Operating Committee, Senior Vice President, and General Manager of Greater China. He also acts as the legal representative and Chairman for all eight of BD’s enterprises in China. Additionally, he is the founding Chairman of the AdvaMed China Council and has been re-elected to this position for four consecutive terms.
Deng Jianmin has nearly thirty years of extensive management experience in the healthcare sector. Prior to joining BD (Becton, Dickinson and Company), he served as Chief Executive Officer and President of Novartis Pharmaceuticals China, and as Vice President of Novartis Pharmaceuticals Corporation (U.S.). Before joining Novartis, he worked at Johnson & Johnson Pharmaceuticals (Xi’an Janssen). Earlier in his career, he spent five years as a faculty member and clinician at medical schools and hospitals.Deng Jianmin graduated successively from the School of Medicine, Zhejiang University; the EMBA program at CEIBS (China Europe International Business School); and the General Management Program (GMP) at Harvard University.
Mr. Deng Jianmin has been honored with such titles as “Most Influential Figure in the Pharmaceutical Industry for the 60th Anniversary of the Founding of the People’s Republic of China,” “Top Ten Industry Figures for Healthy China,” “Influential Figure in the Pharmaceutical Industry in Commemoration of the 40th Anniversary of Reform and Opening-up,” and “Distinguished Alumni” of CEIBS (China Europe International Business School). Mr. Deng is also actively engaged in social initiatives; as a mentor for the “China Health Industry Innovation Platform,” he leverages his personal influence to drive the development of the healthcare sector.Mr. Deng Jianmin currently serves as Vice President of the Health Industry Branch of the China Health Economics Association, Vice President of the Shanghai Alumni Association of CEIBS, and a member of the Jing’an District Committee of the Chinese People’s Political Consultative Conference in Shanghai.
At the summit, we have specially invitedNobel Laureate in Physiology or Medicine, Academician of the Chinese Academy of Sciences and the Chinese Academy of EngineeringDistinguished experts will share cutting-edge domestic and international technologies and frontier medical advancements, focusing on medical development amidst technological transformation, and redefining the evolutionary logic of technology and innovative thinking in the industry.
Executives from leading medical device companies, outstanding innovative entrepreneurs, senior directors of innovation departments, and seasoned investors will focus on ““Growth Curve of the IVD Industry in the Post-Pandemic Era,” “High-Value Consumables Amid Domestic Substitution and Volume-Based Procurement,” and “Innovation in Rehabilitation Products and Application Scenarios in an Aging Society”Three main lines of inquiry are explored in depth.
Currently, the 2014 Nobel Laureate in Physiology or Medicine,Edvard MoserConfirmed participation in this event and will deliver a presentation on"How the Brain Works: A Spatial Systems Approach to Decoding Computation in the Brain"Related Sharing.Academician of the Chinese Academy of Sciences and neurosurgery expert Zhao Jizong, Academician of the Chinese Academy of Engineering Zhang ZhiyuanAll have confirmed their attendance and will deliver relevant presentations.
The 2021 List of Innovative Vitality in Medical Devices is part of the regular series of the Top 100 Future Healthcare Companies. VCBeat, grounded in industry research, identifies high-growth innovative medical device companies by focusing on innovation development, technological advancements, and policy updates in the medical device sector.In Vitro Diagnostics (Digital PCR)、High-Value Consumables (Cardiovascular Interventional)、Rehabilitation Equipment (Rehabilitation Robotics)The rankings across three fundamental dimensions and the “Black Tech” in Medical Devices list selected the 2021 Most Innovative and Vital Medical Device Companies.
The 2021 Medical Device Innovation Vitality List will be announced at the 3rd International Summit on Medical Device Innovation in 2021., and will be promoted through VCBeat's online media matrix.
Edward Moser, 2014 Nobel Prize in Physiology or Medicine
Zhao Jizong, Academician of the Chinese Academy of Sciences, Neurosurgeon
Zhang Zhiyuan, Academician of the Chinese Academy of Engineering
Deng Jianmin, Senior Vice President of BD Worldwide and General Manager of Greater China
Kang Keren, Senior Vice President of Wondfo Biotech
Shen Qin, Partner at Shengyu Investment
Guo Feng, Founder of Zhenzhun Bio
Peng Yifei, General Manager of Tigermed Jietong
Jin Lei, CEO of BaiRen Medical
Wang Jinhe, Vice President of Johnson & Johnson Medical
Yang Zhihao, Vice President of Fourier Intelligence
Xu Junhua, Founder of Aomei Health
More speakers to be confirmed...

You’re Just One Ticket Away from Industry Leaders
Time:Tuesday, June 22, 2021
Location:China · Nanjing (Gaochun District World Village Hotel)
Registration Link:https://5332500000796.huodongxing.com/event/2597428453800

Click the image above or scan the QR code to register for free